Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System

• Autores principales: Concetta Rafaniello (Autor), Carmen Ferrajolo (Autor), Maria Giuseppa Sullo (Autor), Mario Gaio (Autor), Alessia Zinzi (Autor), Cristina Scavone (Autor), Francesca Gargano (Autor), Enrico Coscioni (Autor), Francesco Rossi (Autor), Annalisa Capuano (Autor)
• Formato: Libro
• Publicado: MDPI AG, 2021-06-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Remdesivir was recommended for hospitalized patients with COVID-19. As already reported in the Summary of Product Characteristics, most of remdesivir's safety concerns are hepatoxicity and nephrotoxicity related. However, some cases have raised concerns regarding the potential cardiac events as...